Clinical Trials Insight: 700056839

Trial Profile

Clinical Trials Insight: 700056839

Phase of Trial: Phase I

Latest Information Update: 04 Jun 2010

At a glance

  • Drugs Imgatuzumab (Primary)
  • Indications Solid tumours
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 04 Jun 2010 Results will be presented at the 46th Annual Meeting of ASCO, according to a Roche media release.
    • 04 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top